SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-037823
Filing Date
2020-08-06
Accepted
2020-08-06 16:38:38
Documents
45
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q atrs-10q_20200630.htm   iXBRL 10-Q 1844226
2 EX-31.1 atrs-ex311_8.htm EX-31.1 15728
3 EX-31.2 atrs-ex312_9.htm EX-31.2 15761
4 EX-32.1 atrs-ex321_6.htm EX-32.1 6464
5 EX-32.2 atrs-ex322_7.htm EX-32.2 6475
  Complete submission text file 0001564590-20-037823.txt   5486180

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA atrs-20200630.xsd EX-101.SCH 27603
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE atrs-20200630_cal.xml EX-101.CAL 34609
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE atrs-20200630_def.xml EX-101.DEF 83426
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE atrs-20200630_lab.xml EX-101.LAB 253671
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atrs-20200630_pre.xml EX-101.PRE 186525
11 EXTRACTED XBRL INSTANCE DOCUMENT atrs-10q_20200630_htm.xml XML 998317
Mailing Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628
Business Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628 609-359-3020
ANTARES PHARMA, INC. (Filer) CIK: 0001016169 (see all company filings)

IRS No.: 411350192 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32302 | Film No.: 201082319
SIC: 3841 Surgical & Medical Instruments & Apparatus
Office of Life Sciences